Table 2.

Correlations between Tfh-like cell subsets and the clinical and laboratory characteristics of RA patients.

	Tfh1-like		Tfh2-like		Tfh17-like		Tfh1/17-like
	r	p	r	p	r	p	r	p
Age	0.028	0.852	0.228	0.124	0.423	0.003*	0.315	0.031*
Course	−0.147	0.325	0.038	0.799	0.250	0.090	0.105	0.484
IgA	−0.049	0.760	−0.121	0.450	0.027	0.867	0.132	0.411
IgG	−0.120	0.454	0.004	0.982	0.077	0.631	0.129	0.421
IgM	−0.060	0.711	0.113	0.482	−0.070	0.662	−0.063	0.695
ESR	−0.042	0.781	−0.045	0.765	0.177	0.235	0.285	0.052
CRP	−0.138	0.356	−0.060	0.691	−0.005	0.976	−0.084	0.573
ESR-DAS28	−0.214	0.148	−0.091	0.543	0.223	0.132	0.285	0.052
RF	−0.169	0.258	0.050	0.738	−0.023	0.880	−0.225	0.128
APF	−0.087	0.561	−0.043	0.775	−0.101	0.499	−0.019	0.901
AKA	−0.155	0.299	−0.131	0.380	−0.150	0.315	−0.121	0.417
Anti-MCV	−0.142	0.340	−0.101	0.499	−0.017	0.911	0.134	0.370
Anti-CCP	−0.109	0.466	−0.028	0.854	−0.068	0.650	−0.128	0.390
ANA	0.346	0.017*	0.185	0.212	0.075	0.614	0.363	0.012*

Correlations were assessed using Spearman's rank test.

^*p < 0.05.

AKA, anti-keratin antibody; ANA, anti-nuclear antibody; anti-CCP, anti-cyclic citrullinated peptide; anti-MCV, anti-mutated citrullinated vimentin; APF, anti-perinuclear factor; CRP, C-reactive protein; DAS28, Disease Activity Score-28; RF, rheumatoid factor; ESR, erythrocyte sedimentation rate; Ig, immunoglobulin.